Dana Yaacov-Garbeli - 07 May 2026 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 May 2026, 16:27:47 UTC
Prior SEC filing
18 Jul 2025
Next SEC filing
07 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dana Yaacov-Garbeli

Key filing fact

Dana Yaacov-Garbeli filed Form 4 for Entera Bio Ltd. (ENTX) on 08 May 2026.

Key facts

  • This page summarizes Dana Yaacov-Garbeli's Form 4 filing for Entera Bio Ltd. (ENTX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 08 May 2026, 16:27.

Change

  • Previous filing in this sequence was filed on 18 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001909822 Primary reporting owner

Yaacov-Garbeli Dana

Relationship
Chief Financial Officer
Address
KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, ISRAEL
Signature
/s/ Dana Yaacov-Garbeli
Signature date
08 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENTX transaction

Ordinary Shares, par value NIS 0.0000769 per share

Award

Transaction value
Shares
+58,394
Change %
+52%
Price
$0.000000*
Shares after
171,441
Date
07 May 2026
Ownership
By A2Z Counseling Ltd.
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026.

Footnote F2

These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .